These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
108 related articles for article (PubMed ID: 12788944)
21. PM1-Alpha ELISA: the assay of choice for the detection of anti-PM/Scl autoantibodies? Mahler M; Fritzler MJ Autoimmun Rev; 2009 Mar; 8(5):373-8. PubMed ID: 19103309 [TBL] [Abstract][Full Text] [Related]
22. PM-Scl-75 is the main autoantigen in patients with the polymyositis/scleroderma overlap syndrome. Raijmakers R; Renz M; Wiemann C; Egberts WV; Seelig HP; van Venrooij WJ; Pruijn GJ Arthritis Rheum; 2004 Feb; 50(2):565-9. PubMed ID: 14872500 [TBL] [Abstract][Full Text] [Related]
23. Analysis of the specificity of anti-PM-Scl autoantibodies. Ge Q; Wu Y; Trieu EP; Targoff IN Arthritis Rheum; 1994 Oct; 37(10):1445-52. PubMed ID: 7945469 [TBL] [Abstract][Full Text] [Related]
24. Structure and localization of mouse Pmscl1 and Pmscl2 genes. Bliskovski V; Liddell R; Ramsay ES; Miller MJ; Mock BA Genomics; 2000 Feb; 64(1):106-10. PubMed ID: 10708524 [TBL] [Abstract][Full Text] [Related]
25. Protein-protein interactions between human exosome components support the assembly of RNase PH-type subunits into a six-membered PNPase-like ring. Raijmakers R; Egberts WV; van Venrooij WJ; Pruijn GJ J Mol Biol; 2002 Nov; 323(4):653-63. PubMed ID: 12419256 [TBL] [Abstract][Full Text] [Related]
26. Anti-PM-Scl antibody in patients with systemic sclerosis. Koschik RW; Fertig N; Lucas MR; Domsic RT; Medsger TA Clin Exp Rheumatol; 2012; 30(2 Suppl 71):S12-6. PubMed ID: 22261302 [TBL] [Abstract][Full Text] [Related]
27. Effects of anti-PM-Scl 100 (Rrp6p exonuclease) antibodies on prenucleolar body dynamics at the end of mitosis. Fomproix N; Hernandez-Verdun D Exp Cell Res; 1999 Sep; 251(2):452-64. PubMed ID: 10471330 [TBL] [Abstract][Full Text] [Related]
28. [PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis]. Kim S; Genth E; Krieg T; Hunzelmann N Z Rheumatol; 2005 Oct; 64(7):499-502. PubMed ID: 16244833 [TBL] [Abstract][Full Text] [Related]
29. [Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review]. Marie I; Lahaxe L; Tiev K; Duval-Modeste AB; Vittecoq O; Levesque H; Jouen F Rev Med Interne; 2010 Aug; 31(8):540-4. PubMed ID: 20510485 [TBL] [Abstract][Full Text] [Related]
30. Fluoroenzymeimmunoassay to detect systemic sclerosis-associated antibodies: diagnostic performance and correlation with conventional techniques. Bonroy C; Smith V; Van Steendam K; Van Praet J; Deforce D; Devreese K; De Keyser F Clin Exp Rheumatol; 2012; 30(5):748-55. PubMed ID: 22765957 [TBL] [Abstract][Full Text] [Related]
38. C1D is a major autoantibody target in patients with the polymyositis-scleroderma overlap syndrome. Schilders G; Egberts WV; Raijmakers R; Pruijn GJ Arthritis Rheum; 2007 Jul; 56(7):2449-54. PubMed ID: 17599775 [TBL] [Abstract][Full Text] [Related]
39. Structural and biochemical characterization of the yeast exosome component Rrp40. Oddone A; Lorentzen E; Basquin J; Gasch A; Rybin V; Conti E; Sattler M EMBO Rep; 2007 Jan; 8(1):63-9. PubMed ID: 17159918 [TBL] [Abstract][Full Text] [Related]
40. Cell and molecular biology of the exosome: how to make or break an RNA. Schilders G; van Dijk E; Raijmakers R; Pruijn GJ Int Rev Cytol; 2006; 251():159-208. PubMed ID: 16939780 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]